Prof.Dr. LEYLA OZER

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm

Aktas M. K., AYTAÇ E., YILDIZ İ., OZER L.

The Lancet Oncology , cilt.24, sa.5, 2023 (SCI-Expanded)

Current trends in perioperative treatment of resectable gastric cancer.

Yıldız İ., Özer L., Şenocak Taşçı E., Bayoglu İ. V., Aytac E.

World journal of gastrointestinal surgery , cilt.15, sa.3, ss.323-337, 2023 (SCI-Expanded)

Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement

Aytaç E., Özer L., Baca B., Balık E., Kapran Y., Taşkın O. C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.8, ss.627-663, 2022 (SCI-Expanded)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

Tasci E. S., Oyan B., Sonmez O., Mutlu A. U., Atci M. M., Oner I., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.4, 2022 (SCI-Expanded)

Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?

Özer L., Taşçı E. Ş., Mutlu A. U., Piyade B., Ramoğlu N., Ajredini M., et al.

BALKAN MEDICAL JOURNAL , cilt.39, sa.6, ss.436-443, 2022 (SCI-Expanded)

Clinicopathological and Prognostic Significance of MSI Status and PD-L1 Expression in Turkish Patients with Gastric Cancer

Bahsi S., YILDIZ İ., Erdamar S., Goksel S., Tozun N., AYTAÇ E., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.4, ss.246-254, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , sa.7, ss.584-598, 2019 (SCI-Expanded)

The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma

TUNÇER Ş. B., AKDENİZ ÖDEMİŞ D., ÇELİK B., KILIÇ ERCİYAS S., Sukruoglu O., Avsar M., et al.

MOLECULAR BIOLOGY REPORTS , cilt.46, sa.1, ss.975-980, 2019 (SCI-Expanded)

Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy.

Yildiz İ., Bilici A., Karadurmus N., Ozer L., Tural D., Kaplan M. A., et al.

Tumori , cilt.104, sa.6, ss.444-450, 2018 (SCI-Expanded)

Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience.

Kılıç L., Ekenel M., Karabulut S., Ağaoğlu F., Darendeliler E.

Contemporary oncology (Poznan, Poland) , cilt.21, ss.60-65, 2017 (SCI-Expanded)

Clinical significance of serum interleukin-17 levels in colorectal cancer patients

KARABULUT S., Afsar C. U., Karabulut M., Kilic L., Alis H., Kones O., et al.

JOURNAL OF BUON , cilt.21, sa.5, ss.1137-1145, 2016 (SCI-Expanded)

Current adjuvant treatment modalities for gastric cancer: From history to the future

Kilic L., Ordu C., Yildiz İ., Sen F., Keskin S., Ciftci R., et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.8, sa.5, ss.439-449, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

JOURNAL OF DERMATOLOGICAL TREATMENT , cilt.27, sa.3, ss.275-277, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer

TAŞ F., YILDIZ İ., Kilic L., Ciftci R., Keskin S., Sen F.

AMERICAN JOURNAL OF THERAPEUTICS , cilt.23, sa.3, 2016 (SCI-Expanded)

Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma

Sen F., Yildiz İ., Odabas H., Tambas M., Kilic L., Karadeniz A., et al.

TUMOR BIOLOGY , cilt.36, sa.2, ss.1039-1044, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients

Kilic L., YILDIZ İ., Sen F. K., Erdem M. G., SERİLMEZ M., Keskin S., et al.

CANCER BIOMARKERS , cilt.15, sa.4, ss.405-411, 2015 (SCI-Expanded)

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.

Yildiz İ., Varol U., Sen F., Kilic L.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology , cilt.14, sa.7, ss.654-6, 2014 (SCI-Expanded)

The behavior of Turkish cancer patients in fasting during the holy month of Ramadan.

TAŞ F., KARABULUT S., Ciftci R., YILDIZ İ., Keskin S., Kilic L., et al.

Japanese journal of clinical oncology , cilt.44, sa.8, ss.705-10, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer.

Ciftci R., TAŞ F., TİLGEN YASASEVER C., Aksit E., KARABULUT S., Sen F., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.35, sa.7, ss.6941-8, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Coagulation tests show significant differences in patients with breast cancer

TAŞ F., Kilic L., DURANYILDIZ H. D.

TUMOR BIOLOGY , cilt.35, sa.6, ss.5985-5992, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up

ELİTOK A., Oz F., Cizgici A. Y., Kilic L., Ciftci R., Sen F., et al.

CARDIOLOGY JOURNAL , cilt.21, sa.5, ss.509-515, 2014 (SCI-Expanded)

Aspirin resistance in patients with impaired renal functions

Aksu H. U., Oner E., Erturk M., Aksu H., Isiksacan N., Ozalp B., et al.

KARDIOLOGIA POLSKA , cilt.72, sa.4, ss.331-338, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Age is a prognostic factor affecting survival in lung cancer patients

TAŞ F., Ciftci R., Kilic L., KARABULUT S.

ONCOLOGY LETTERS , cilt.6, sa.5, ss.1507-1513, 2013 (SCI-Expanded)

Performance status of patients is the major prognostic factor at all stages of pancreatic cancer.

TAŞ F., Sen F., Odabas H., Kilic L., Keskin S., YILDIZ İ.

International journal of clinical oncology , cilt.18, sa.5, ss.839-46, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Serum M65 as a biomarker for metastatic renal cell carcinoma.

YILDIZ İ., Sen F., Kilic L., Keskin S., DURANYILDIZ H. D., Bilgin E., et al.

Clinical genitourinary cancer , cilt.11, sa.3, ss.290-6, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Yildiz İ., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.72, sa.2, ss.437-444, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.

Sen F., Yildiz İ., Başaran M., Ekenel M., Oz F., Kilic L., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.18, sa.3, ss.775-81, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

TAŞ F., AYDOĞMUŞ ŞEN F., Keskin S., Kilic L.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.27, sa.6, ss.789-792, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).

Keskin S., YILDIZ İ., AYDOĞMUŞ ŞEN F., AYDOĞAN F., Kilic L., EKENEL M., et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , cilt.15, sa.5, ss.403-8, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Aydiner A., Kilic L., Yildiz İ., Keskin S., Sen F., Kucucuk S., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.1, ss.354, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical and prognostic significance of coagulation assays in lung cancer

TAŞ F., Kilic L., SERİLMEZ M., Keskin S., Sen F., DURANYILDIZ H. D.

RESPIRATORY MEDICINE , cilt.107, sa.3, ss.451-457, 2013 (SCI-Expanded)

Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.

TAŞ F., Kilic L., Bilgin E., Keskin S., Sen F., Ciftci R., et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , cilt.23, sa.2, ss.276-81, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?

AYDINER A., Ciftci R., KARABULUT S., Kilic L.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.10, ss.6109-6114, 2013 (SCI-Expanded)

Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Kilic L., Ordu C., EKENEL M., YILDIZ İ., Keskin S., Sen F., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.3, ss.660, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.

Aykan N. F., Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.3, ss.679, 2013 (SCI-Expanded)

Clinical and prognostic significance of coagulation assays in melanoma.

TAŞ F., Ciftci R., Kilic L., Bilgin E., Keskin S., Sen F., et al.

Melanoma research , cilt.22, sa.5, ss.368-75, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

ŞANLI Y., KUYUMCU S., ÖZKAN Z. G., Kilic L., Balik E., TÜRKMEN C., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.26, sa.7, ss.551-558, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.

TAŞ F., Keskin S., Karadeniz A., Dagoglu N., Sen F., Kilic L., et al.

Oncology , cilt.81, sa.5-6, ss.353-8, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.

Yildiz İ., Sen F., Tuncer S., Kilic L., Basaran M., Bavbek S.

Onkologie , cilt.34, sa.11, ss.630-3, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Diğer Dergilerde Yayınlanan Makaleler

The technical details of robotic-assisted mitral valve replacement

GÜLLÜ A. Ü., SENAY S., Ersin E., KOÇYİĞİT M., OZER L., ÇELİK Ö., et al.

Journal of Visualized Surgery , cilt.9, 2023 (Scopus)

The Youngest Patient with Metastatic Leiomyosarcoma of the Pancreas.

Saka D., Şişman G., Özer L., Şahin D., Ceyhan G.

Journal of gastrointestinal cancer , cilt.51, ss.722-723, 2020 (ESCI)

Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma

KARABULUT S., Afsar Ç. U., Karabulut M., Alış H., Kılıc L., Çikot M., et al.

Journal of Gastrointestinal Cancer , cilt.47, sa.1, ss.47-54, 2016 (Scopus) Sürdürülebilir Kalkınma

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience

Eralp Y., Kilic L., Alco G., BAŞARAN G., Dogan M., Dincol D., et al.

JOURNAL OF BREAST HEALTH , cilt.10, sa.4, ss.209-215, 2014 (ESCI)

Intolerance to sunitinib treatment in hemodialysis patients with metastatic renal cell carcinoma.

YILDIZ İ., Sen F., Kilic L., Ciftci R., BAŞARAN M.

Korean journal of urology , cilt.55, sa.1, ss.74-6, 2014 (Hakemli Dergi)

Clinical and prognostic significance of coagulation assays in gastric cancer

TAŞ F., Ciftci R., Kilic L., SERİLMEZ M., KARABULUT S., Duranyildiz D.

Journal of Gastrointestinal Cancer , cilt.44, sa.3, ss.285-292, 2013 (Scopus) Sürdürülebilir Kalkınma

Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.

TAŞ F., Sen F., Keskin S., Kilic L., YILDIZ İ.

Molecular and clinical oncology , cilt.1, sa.4, ss.788-792, 2013 (Hakemli Dergi) Sürdürülebilir Kalkınma

Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma

TAŞ F., KARABULUT S., Bilgin E., Kılıc L., Ciftci R., Duranyildiz D.

Journal of Gastrointestinal Cancer , cilt.44, sa.4, ss.404-409, 2013 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Karaciğer Metastazı Olan Evre IV Kolorektal Kanser Hastalarının Küratif Tedavisinin Planlanmasında Multidisipliner Tümör Konseyi Kararlarının Etkisi

Cakcak İ. E., Aytaç E., Özben V., Özer L., Yıldız İ., Gönenç M., et al.

22. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 23 - 27 Mart 2022, ss.10

Positive MRI findings in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy

Erdemli S., Taşkın F., Erdoğdu İ. H., Tokat F., Behzatoğlu K., Meydan N., et al.

European Congress of Radiology, Vienna, Avusturya, 3 - 07 Mart 2021, ss.164-165 Sürdürülebilir Kalkınma

Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDI-1 expression in Turkish patients with gastric cancer.

Yildiz İ., Bahsi S., Erdamar S., Goksel S., Demir G., Er O., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 Sürdürülebilir Kalkınma

Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33

Distribution and frequency of BRCA gene mutations in Turkish population including Balkan Turks

Akdeniz D., Tuncer B. S., Kilic S., Sukruoglu O., Kilic L., Altundag K., et al.

AACR Special Conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, California, Amerika Birleşik Devletleri, 29 Ocak - 01 Şubat 2014, cilt.74

Clinical and pathologic characteristics of ovarian cancer patients with BRCA1 and BRCA2 mutations in Turkish population

SAİP P. M., Akdeniz B., Tuncer B., Kilic S., Sukruoglu O., Altundag K., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32

Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

Ciftci R., TAŞ F., Aksit E., VATANSEVER S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma

Serum inflammatory parameters as prognostic factors in patients with gastic cancer: Is serum albumin the best inflammotory biomarker predicting prognosis?

Sen F., Zobaci E., Erdemli H. K., Kocabas R., Kilic L., Ylidiz I.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32

Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma

KARABULUT S., Aykan N. F., Yildiz İ., Kilic L., Sen F., VATANSEVER S.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 16 - 18 Ocak 2014, cilt.32

Is there any prognostic importance of pretreatment serum M30 and serum M65 levels on progression-free survival of patients with metastatic renal cell carcinoma treated with first-line sunitinib?

BAŞARAN M., Yildiz İ., Sen F., Kilic L., Keskin S., Darendeliler E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31

Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy

Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., EKENEL M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma

Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., KARABULUT S., Yildiz İ., Kilic L., Sen F., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31

Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

KARABULUT S., Kilic L., Ciftci R., Yildiz İ., Sen F., Keskin S., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma

Berrak Hücreli Sarkom Bir olgu nedeniyle

GÜRAL Z., OSKEROĞLU S., ERGÜN S., KILIÇ L., AKGÜN Z., YÜCEL S., et al.

20. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2013

Kitap & Kitap Bölümleri

ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER

Ozer L., Aydıner A.

BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , ADNAN AYDINER,ATILLA SORAN,ABDULLAH IGCI, Editör, Springer, London/Berlin , Geneve, ss.357-383, 2019 Sürdürülebilir Kalkınma

Metrikler

Yayın

Atıf (WoS)

712

H-İndeks (WoS)

Atıf (Scopus)

735

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler